Literature DB >> 25059464

Recent advances in visualizing vulnerable plaque: focus on noninvasive molecular imaging.

Gezim Bala1, Bernard Cosyns.   

Abstract

Traditional imaging methods in atherosclerosis have focused primarily on anatomic information. Imaging approaches that visualize molecular targets rather than anatomic structures may emphasize biologic aspects of atherosclerosis. Molecular imaging of atherosclerotic lesions has become a crucial experimental tool and is now emerging in the clinical arena. In this review, we briefly highlight the rationale and fundamental principles of molecular imaging. We then discuss the promising imaging modalities, along with their potential limitations, and the molecular targets being investigated in experimental research. Finally, we summarize the most important clinical studies recently performed in humans.

Entities:  

Mesh:

Year:  2014        PMID: 25059464     DOI: 10.1007/s11886-014-0520-5

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  79 in total

1.  Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages.

Authors:  Rikin A Trivedi; Chinthake Mallawarachi; Jean-Marie U-King-Im; Martin J Graves; Jo Horsley; Martin J Goddard; Andrew Brown; Liqun Wang; Peter J Kirkpatrick; John Brown; Jonathan H Gillard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-20       Impact factor: 8.311

2.  An updated coronary risk profile. A statement for health professionals.

Authors:  K M Anderson; P W Wilson; P M Odell; W B Kannel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

3.  In vivo imaging of mineral deposition in carotid plaque using 18F-sodium fluoride PET/CT: correlation with atherogenic risk factors.

Authors:  Thorsten Derlin; Christian Wisotzki; Ulrich Richter; Ivayla Apostolova; Peter Bannas; Christoph Weber; Janos Mester; Susanne Klutmann
Journal:  J Nucl Med       Date:  2011-02-14       Impact factor: 10.057

4.  Arterial foci of F-18 fluorodeoxyglucose are associated with an enhanced risk of subsequent ischemic stroke in cancer patients: a case-control pilot study.

Authors:  Solène Grandpierre; Emmanuel Desandes; Benoit Meneroux; Wassila Djaballah; Damien Mandry; Fanny Netter; Denis Wahl; Renaud Fay; Gilles Karcher; Pierre-Yves Marie
Journal:  Clin Nucl Med       Date:  2011-02       Impact factor: 7.794

5.  Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study.

Authors:  Thorsten Derlin; Zoltán Tóth; László Papp; Christian Wisotzki; Ivayla Apostolova; Christian R Habermann; Janos Mester; Susanne Klutmann
Journal:  J Nucl Med       Date:  2011-06-16       Impact factor: 10.057

6.  Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions.

Authors:  Alexis Broisat; Sophie Hernot; Jakub Toczek; Jens De Vos; Laurent M Riou; Sandrine Martin; Mitra Ahmadi; Nicole Thielens; Ulrich Wernery; Vicky Caveliers; Serge Muyldermans; Tony Lahoutte; Daniel Fagret; Catherine Ghezzi; Nick Devoogdt
Journal:  Circ Res       Date:  2012-03-30       Impact factor: 17.367

Review 7.  FDG PET imaging and cardiovascular inflammation.

Authors:  Nadine Hiari; James H F Rudd
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

8.  18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease.

Authors:  Axel Rominger; Tobias Saam; Sarah Wolpers; Clemens C Cyran; Michael Schmidt; Stefan Foerster; Konstantin Nikolaou; Maximilian F Reiser; Peter Bartenstein; Marcus Hacker
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

Review 9.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

10.  Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.

Authors:  Iina Laitinen; Antti Saraste; Eliane Weidl; Thorsten Poethko; Axel W Weber; Stephan G Nekolla; Pia Leppänen; Seppo Ylä-Herttuala; Gabriele Hölzlwimmer; Axel Walch; Irene Esposito; Hans-Jürgen Wester; Juhani Knuuti; Markus Schwaiger
Journal:  Circ Cardiovasc Imaging       Date:  2009-05-13       Impact factor: 7.792

View more
  2 in total

Review 1.  Recent Advances of Radionuclide-Based Molecular Imaging of Atherosclerosis.

Authors:  Soraya M Kazuma; Deborah Sultan; Yongfeng Zhao; Lisa Detering; Meng You; Hannah P Luehmann; Dulcineia S P Abdalla; Yongjian Liu
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

2.  Cellular Uptake of Plain and SPION-Modified Microbubbles for Potential Use in Molecular Imaging.

Authors:  Mona Ahmed; Barbara Cerroni; Anton Razuvaev; Johan Härmark; Gaio Paradossi; Kenneth Caidahl; Björn Gustafsson
Journal:  Cell Mol Bioeng       Date:  2017-08-10       Impact factor: 2.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.